Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

By D. Yach, D. Stuckler, K. Brownell. Nature Medicine, 2006

915 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/04af72e70f64f00ea00dd48e0df7842cd99d9690

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. J. Hughes
2. R. Holmer
3. Brandon H Hidaka
4. J. Keatinge
5. K. Dodd
6. W. Easdown
7. Ray-yu Yang

Citations in the corpus

• Effect of Obesity on the Pharmacokinetics of Drugs in Humans (2010, background): “Although it was originally seen as an issue only in developed nations, current evidence demonstrates an increase in obesity prevalence in many lower- and middle-income countries.([1,2]) In 2005, the WHO estimated the numbers of overweight and obese adults to be 1.”
• Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (2011, background): “In our modern, sedentary lifestyle with calorie-rich diets, such adaptive mechanisms could be seriously overwhelmed, causing an epidemic of obesity and T2D worldwide (Yach et al., 2006).”
• Physical activity in the United States measured by accelerometer. (2008, background): “population (16), as well as among residents of countries around the world (18,34).”
• The importance of vegetables in ensuring both food and nutritional security in attainment of the Millennium Development Goals (2011, background): “…precursors of obesity-derived ill health associated with noncommunicable disease conditions such as type II diabetes, hypertension and cardiac issues (Yach et al. 2006), which are significant causes of mortality and cost health care systems hundreds of billions of US dollars (Hogan et al. 2003).”
• Critical role for peptide YY in protein-mediated satiation and body-weight regulation. (2006, background): “The obesity epidemic has profound healthcare implications (Yach et al., 2006).”
• NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential (2020, background): “Insulin resistance is a critical whole-body abnormal metabolism closely related to obesity.(445,446) A reduction of NAD levels in cells is observed in many tissues with obesity, like the skeletal muscles, hypothalamus, liver and adipose tissue.”
• Depression as a disease of modernity: explanations for increasing prevalence (2012, background): “As the leading cause of morbidity and mortality, diseases of modernity are the greatest threat to public health in the developed world (Yach et al., 2006).”
• COVID-19 and finance: Agendas for future research (2020, neutral): “(2017) ; Tam, Khan, and Legido-Quigley (2016) ; Yach, Stuckler, and Brownell (2006) and many others.”